Videos de Experimentos Relacionados
El tinnitus que pone en peligro la vida.
S Javaheri1, V Cohen, I Libman
1Department of Internal Medicine, Jewish General Hospital, McGill University, Montréal, Qc, Canada.
Lancet (London, England)
|November 9, 2000
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance.
Journal of endocrinological investigation·2024
Same author
Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases.
Eye (London, England)·2022
Same author
What Factors Influence Dental Faculty's Willingness to Treat Pregnant Women?
JDR clinical and translational research·2021
Same author
Understanding clinical practice and survival outcomes in patients with unresectable stage III non-small-cell lung cancer in a single centre in Quebec.
Current oncology (Toronto, Ont.)·2020
Same author
Erratum to "The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma" [Lung Cancer 132 (June) (2019) 36-38].
Lung cancer (Amsterdam, Netherlands)·2019
Same author
The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands)·2019
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026